CPT2 and neoplasm: Among the prognostic risk model genes, TYRO3 and CPT2 demonstrated strong tumor-suppressive potential, aligning with mRNA-level analyses in which both genes showed negative correlation coefficients within the risk model—further supporting their protective roles in KIRC.